Moleculin Biotech, Inc. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
Moleculin Biotech, Inc. (MBRX) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $15.97 million as of 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2026-03-18
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $15.97M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $12.96M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $11.60M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $11.02M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic |
|---|---|
| 2025-12-31 | $15.97M 10-K · filed 2026-03-18 |
| 2024-12-31 | $12.96M 10-K · filed 2026-03-18 |
| 2023-12-31 | $11.60M 10-K · filed 2025-03-21 |
| 2022-12-31 | $11.02M 10-K · filed 2024-03-22 |
| 2021-12-31 | $10.87M 10-K · filed 2023-03-22 |
| 2020-12-31 | $7.98M 10-K · filed 2022-03-24 |
| 2019-12-31 | $5.38M 10-K · filed 2021-03-24 |
| 2018-12-31 | $3.15M 10-K · filed 2020-03-19 |
| 2017-12-31 | $1.27M 10-K · filed 2019-02-21 |
| 2016-12-31 | $520.00K 10-K · filed 2018-03-28 |
| 2015-12-31 | $89.00K 10-K · filed 2017-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |